Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Illness01:17

Classification of Illness

8.5K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.5K
Classification of Systems-I01:26

Classification of Systems-I

543
Linearity is a system property characterized by a direct input-output relationship, combining homogeneity and additivity.
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
543
Classification of Neurotransmitters01:30

Classification of Neurotransmitters

5.0K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
5.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses.

Journal of neuroinflammation·2026
Same author

FTLD-TDP versus LATE-NC: Experience of a Brain Bank specializing in FTLD-TDP.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Neuroradiological patterns and prognostic implications in type I Alexander disease.

Molecular genetics and metabolism·2026
Same author

Highlighting the value of polymyography in childhood onset movement disorders.

Frontiers in neurology·2026
Same author

Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction.

Science translational medicine·2026
Same journal

Predicting Chemotherapy Response from Staging Laparoscopy Images.

medRxiv : the preprint server for health sciences·2026
Same journal

Development and External Validation of a Machine Learning Model for 10-Year Ischemic Stroke Risk Prediction in Diverse Populations.

medRxiv : the preprint server for health sciences·2026
Same journal

MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative.

medRxiv : the preprint server for health sciences·2026
Same journal

Genetic and maternal environmental contributions to estimated fetal weight at 20 weeks gestation compared with birthweight.

medRxiv : the preprint server for health sciences·2026
Same journal

Better immediate declarative memory is associated with forgetting during locomotor adaptation in chronic stroke and in older adults.

medRxiv : the preprint server for health sciences·2026
Same journal

An empirical Bayes framework for burden and dispersion association tests helps prioritize rare variants associated with Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.3K

Agentic Generative Artificial Intelligence System for Classification of Pathology-Confirmed Primary Progressive

Chiara Gallingani, Zachary A Miller, Maria Luisa Mandelli

    Medrxiv : the Preprint Server for Health Sciences
    |November 24, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Generative artificial intelligence (AI) achieved expert-level accuracy in diagnosing Primary Progressive Aphasia (PPA) variants and pathologies using multimodal data. This AI system shows promise for improving diagnostic accessibility in neurodegenerative diseases.

    More Related Videos

    Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
    05:33

    Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

    Published on: July 11, 2025

    763
    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    18.1K

    Related Experiment Videos

    Last Updated: Jan 10, 2026

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
    08:04

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

    Published on: June 6, 2025

    1.3K
    Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
    05:33

    Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

    Published on: July 11, 2025

    763
    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    18.1K

    Area of Science:

    • Neuroscience and Artificial Intelligence
    • Diagnostic accuracy in neurodegenerative diseases

    Background:

    • Accurate diagnosis is crucial for neurodegenerative diseases, especially with new therapies.
    • Primary Progressive Aphasia (PPA) diagnosis is complex due to varied presentations and data integration challenges.
    • Generative AI offers potential for scalable diagnostic support in complex neurological conditions.

    Purpose of the Study:

    • To assess the diagnostic performance of an agentic generative AI system for classifying PPA.
    • To evaluate AI's ability to determine PPA clinical syndromes and underlying pathologies.

    Main Methods:

    • A retrospective diagnostic validation study utilized a multi-agent generative AI architecture.
    • The AI processed multimodal data: clinical notes, neuropsychological tests, and MRI scans from 54 PPA patients.
    • The system performed open-ended and constrained classifications against gold-standard post-mortem diagnoses.

    Main Results:

    • The AI achieved 90.7% accuracy in identifying PPA cases in an open-ended setting.
    • Classification accuracy for PPA variants was high: 100% for semantic (svPPA) and nonfluent (nfvPPA), 94.1% for logopenic (lvPPA).
    • Neuropathological prediction accuracy reached 100% for FTLD-TDP type C and FTLD-4R tau, and 94.4% for Alzheimer's disease; the entire process took under 10 minutes.

    Conclusions:

    • The generative AI system demonstrated expert-level diagnostic performance for PPA, integrating multimodal data effectively.
    • The AI's speed and accuracy suggest potential for expanding access to specialized diagnostic expertise.
    • Further validation in diverse patient populations is recommended for broader clinical application.